^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

FER (FER Tyrosine Kinase)

i
Other names: FER, FER Tyrosine Kinase, TYK3, PPP1R74, Fujinami Poultry Sarcoma/Feline Sarcoma-Related Protein Fer, Protein Phosphatase 1, Regulatory Subunit 74, Feline Encephalitis Virus-Related Kinase FER, Fer (Fps/Fes Related) Tyrosine Kinase, Tyrosine-Protein Kinase Fer, Phosphoprotein NCP94, Proto-Oncogene C-Fer, Tyrosine Kinase 3, P94-Fer
9d
Ferrostatin-1 attenuates sepsis-induced lung injury by inhibiting ferroptosis via activation of the SLC7A11/GSH/GPX4 signaling pathway. (PubMed, J Chromatogr B Analyt Technol Biomed Life Sci)
In sepsis-induced lung injury, the ferroptosis-related SLC7A11/GSH/GPX4 signaling pathway is downregulated. Ferrostatin-1 activates this pathway and protects the lungs.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • GPX4 (Glutathione Peroxidase 4) • PTGS2 (Prostaglandin-Endoperoxide Synthase 2) • FER (FER Tyrosine Kinase) • SLC7A11 (Solute Carrier Family 7 Member 11) • PACERR (PTGS2 Antisense NFKB1 Complex-Mediated Expression Regulator RNA)
|
erastin
2ms
DEAF1 confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma. (PubMed, Drug Resist Updat)
Our findings demonstrate that DEAF1 attenuates ADR-induced apoptosis and pyroptosis in MM by enhancing DNA damage repair and suppressing GSDME cleavage via the FER/GSDME axis. This study provides a novel therapeutic target for the treatment of MM.
Journal
|
RAD50 (RAD50 Double Strand Break Repair Protein) • CASP3 (Caspase 3) • FER (FER Tyrosine Kinase) • GSDME (Gasdermin E) • TFAP2A (Transcription Factor AP-2 Alpha)
|
doxorubicin hydrochloride
4ms
Andrographolide induces ferroptosis in colorectal cancer via P53-mediated downregulation of the SLC7A11/GPX4 signaling pathway. (PubMed, Phytomedicine)
Our data demonstrate that AP can induce ferroptosis in colorectal cancer by downregulating the SLC7A11/GPX4 signaling pathway, with P53 potentially serving as its target.
Journal
|
GPX4 (Glutathione Peroxidase 4) • FER (FER Tyrosine Kinase) • SLC7A11 (Solute Carrier Family 7 Member 11)
|
erastin
6ms
Inhibition of dipeptidyl peptidase 9 improves sorafenib sensitivity by inducing ferroptosis in hepatocellular carcinoma. (PubMed, J Cancer Res Clin Oncol)
Inhibition of DPP9 improves sorafenib sensitivity by promoting ferroptosis in HCC, which provides novel evidence for DPP9 as an HCC treatment target synergizing with sorafenib.
Journal
|
FER (FER Tyrosine Kinase) • ACSL4 (Acyl-CoA Synthetase Long Chain Family Member 4) • SLC7A11 (Solute Carrier Family 7 Member 11)
|
sorafenib
7ms
Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis. (PubMed, NPJ Precis Oncol)
In summary, FER could serve as a prognostic indicator and therapeutic target in DLBCL. Additionally, the application of exosomes in diagnosis or treatment may open up novel avenues for cancer therapy.
Journal
|
FER (FER Tyrosine Kinase) • AJUBA (Ajuba LIM Protein)
8ms
Ping-Chong-Jiang-Ni Formula effectively inhibits migration and invasion of endometriosis 12Z cell line via TRIP13. (PubMed, J Food Drug Anal)
Additionally, after PCJNF treatment, we observed significant alterations in the expression of migration-and invasion-related proteins, such as vimentin and E-cadherin. In conclusion, these findings suggest that TRIP13 may serve as a potential therapeutic target for EMs and that PCJNF offers a promising new approach for integrating Traditional Chinese Medicine with modern medical treatments.
Preclinical • Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • CDH1 (Cadherin 1) • VIM (Vimentin) • FER (FER Tyrosine Kinase) • TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1) • TRIP13 (Thyroid Hormone Receptor Interactor 13)
10ms
Novel ACTB::FER Promoter Swap Fusion Characterizes Rare Superficial Myoid/Myofibroblastic Tumors. (PubMed, Genes Chromosomes Cancer)
We report the first two cases of soft tissue tumors harboring ACTB::FER fusions and expand the molecular spectrum of mesenchymal tumors with kinase gene alterations. Further, we highlight the importance of target-agnostic approaches for the detection of rare kinase fusions, which may not be included on targeted next-generation sequencing panels.
Journal
|
FER (FER Tyrosine Kinase)
11ms
A correlation study of serum tumor markers with systemic lupus erythematosus-associated interstitial lung disease. (PubMed, Front Med (Lausanne))
Serum levels of CA125, CA15-3, and CA19-9 could act as associated markers for SLE-ILD. Serum SCC, CYFRA21-1 and FER levels may also be linked to kidney involvement in SLE-ILD.
Journal
|
CEACAM5 (CEA Cell Adhesion Molecule 5) • MUC16 (Mucin 16, Cell Surface Associated) • FER (FER Tyrosine Kinase) • KRT19 (Keratin 19) • CA 19-9 (Cancer antigen 19-9)
1year
Genetic variants of FER and SULF1 in the fibroblast-related genes are associated with non-small-cell lung cancer survival. (PubMed, Int J Cancer)
Expression quantitative trait loci analysis indicated that the FER rs7716388 G allele was associated with the up-regulation of FER mRNA expression levels in lung tissue. Our results indicated that these two functional SNPs in the FRGs may be prognostic biomarkers for the prognosis of NSCLC patients, and the possible mechanism may be through modulating the expression of their corresponding genes.
Journal
|
FER (FER Tyrosine Kinase)
1year
Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis. (PubMed, J Pharm Pharmacol)
Piperlongumine inhibits Glioblastoma multiforme proliferation by inducing ferroptosis in vitro and vivo model.
Journal
|
NFE2L2 (Nuclear Factor, Erythroid 2 Like 2) • FER (FER Tyrosine Kinase)
|
NFE2L2 overexpression
1year
Identification of a novel SH3PXD2B::FER fusion in a case of plexiform myofibroblastic tumor and review of the literature. (PubMed, Genes Chromosomes Cancer)
To our knowledge, the SH3PXD2B::FER fusion has never been reported previously. Whether the current case represents an example of a plexiform myofibroblastic tumor or a distinct tumor entity remains to be determined.
Review • Journal
|
EGFR (Epidermal growth factor receptor) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • CD34 (CD34 molecule) • FER (FER Tyrosine Kinase) • SH3PXD2B (SH3 And PX Domains 2B)
|
EGFR positive
1year
CRISPR-Cas9 screening identifies the role of FER as a tumor suppressor. (PubMed, J Pathol)
Taken together, our findings not only provide insights into the essential role of FER as a tumor suppressor in tumor initiation and progression but also highlight its potential as a target for future clinical diagnosis.
Journal
|
FER (FER Tyrosine Kinase)